143 related articles for article (PubMed ID: 36127617)
21. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
22. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
[TBL] [Abstract][Full Text] [Related]
23. Rapid liquid chromatography-tandem mass spectrometry to determine very-long-chain fatty acids in human and to establish reference intervals for the Chinese population.
Wang D; Yu S; Zhang Y; Yin Y; Cheng Q; Xie S; Yu J; Li H; Cheng X; Qiu L
Clin Chim Acta; 2019 Aug; 495():185-190. PubMed ID: 30978326
[TBL] [Abstract][Full Text] [Related]
24. A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Semeraro M; Rizzo C; Boenzi S; Cappa M; Bertini E; Antonetti G; Dionisi-Vici C
Clin Chim Acta; 2016 Jul; 458():159-64. PubMed ID: 27189059
[TBL] [Abstract][Full Text] [Related]
25. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
26. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
27. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
28. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
29. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
[TBL] [Abstract][Full Text] [Related]
30. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
Kase BF; Björkhem I
Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
[TBL] [Abstract][Full Text] [Related]
31. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
32. Bile acids in peroxisomal disorders.
Van Eldere JR; Parmentier GG; Eyssen HJ; Wanders RJ; Schutgens RB; Vamecq J; Van Hoof F; Poll-The BT; Saudubray JM
Eur J Clin Invest; 1987 Oct; 17(5):386-90. PubMed ID: 2446876
[TBL] [Abstract][Full Text] [Related]
33. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
34. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
35. Identification of long and very long chain fatty acids, plasmalogen-C16:0 and phytanic acid as new lipid biomarkers in Tunisian coronary artery disease patients.
Hadj Ahmed S; Koubaa N; Kharroubi W; Zarrouk A; Mnari A; Batbout F; Gamra H; Hammami S; Lizard G; Hammami M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():49-58. PubMed ID: 28789919
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical characteristics of peroxisomal disorders: an update.
Wanders RJ; Barth PG; Schutgens RB; Tager JM
Eur J Pediatr; 1994; 153(7 Suppl 1):S44-8. PubMed ID: 7957386
[TBL] [Abstract][Full Text] [Related]
37. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry.
Valianpour F; Selhorst JJ; van Lint LE; van Gennip AH; Wanders RJ; Kemp S
Mol Genet Metab; 2003 Jul; 79(3):189-96. PubMed ID: 12855224
[TBL] [Abstract][Full Text] [Related]
38. Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome.
Govaerts L; Bakkeren J; Monnens L; Maas J; Trijbels F; Kleijer W
J Inherit Metab Dis; 1985; 8(1):5-8. PubMed ID: 3921760
[TBL] [Abstract][Full Text] [Related]
39. Ataxia associated with increased plasma concentrations of pristanic acid, phytanic acid and C27 bile acids but normal fibroblast branched-chain fatty acid oxidation.
Clayton PT; Johnson AW; Mills KA; Lynes GW; Wilson J; Casteels M; Mannaerts G
J Inherit Metab Dis; 1996; 19(6):761-8. PubMed ID: 8982949
[TBL] [Abstract][Full Text] [Related]
40. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders.
Peduto A; Baumgartner MR; Verhoeven NM; Rabier D; Spada M; Nassogne MC; Poll-The BT; Bonetti G; Jakobs C; Saudubray JM
Mol Genet Metab; 2004 Jul; 82(3):224-30. PubMed ID: 15234336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
